Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs IND. SWIFT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES IND. SWIFT ZYDUS LIFESCIENCES/
IND. SWIFT
 
P/E (TTM) x 22.0 2.1 1,068.2% View Chart
P/BV x 4.8 - - View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ZYDUS LIFESCIENCES   IND. SWIFT
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-24
IND. SWIFT
Mar-24
ZYDUS LIFESCIENCES/
IND. SWIFT
5-Yr Chart
Click to enlarge
High Rs1,03024 4,241.0%   
Low Rs4837 6,796.5%   
Sales per share (Unadj.) Rs194.392.7 209.5%  
Earnings per share (Unadj.) Rs38.12.6 1,449.1%  
Cash flow per share (Unadj.) Rs45.77.6 598.4%  
Dividends per share (Unadj.) Rs3.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs197.1-127.6 -154.5%  
Shares outstanding (eoy) m1,006.2354.16 1,857.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.90.2 2,300.2%   
Avg P/E ratio x19.96.0 332.5%  
P/CF ratio (eoy) x16.62.1 805.3%  
Price / Book Value ratio x3.8-0.1 -3,118.9%  
Dividend payout %7.90-   
Avg Mkt Cap Rs m761,065850 89,525.0%   
No. of employees `000NANA-   
Total wages/salary Rs m27,890729 3,824.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m195,4745,022 3,892.0%  
Other income Rs m3,694580 637.0%   
Total revenues Rs m199,1685,602 3,555.0%   
Gross profit Rs m52,848485 10,893.4%  
Depreciation Rs m7,641271 2,818.8%   
Interest Rs m812629 129.0%   
Profit before tax Rs m48,089165 29,208.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,77522 43,794.8%   
Profit after tax Rs m38,314142 26,922.9%  
Gross profit margin %27.09.7 279.9%  
Effective tax rate %20.313.6 149.9%   
Net profit margin %19.62.8 691.7%  
BALANCE SHEET DATA
Current assets Rs m114,1983,418 3,341.1%   
Current liabilities Rs m53,3973,204 1,666.7%   
Net working cap to sales %31.14.3 729.1%  
Current ratio x2.11.1 200.5%  
Inventory Days Days3056 53.0%  
Debtors Days Days971,106 8.8%  
Net fixed assets Rs m161,3523,127 5,160.3%   
Share capital Rs m1,006108 928.6%   
"Free" reserves Rs m197,289-7,017 -2,811.8%   
Net worth Rs m198,295-6,908 -2,870.4%   
Long term debt Rs m010,095 0.0%   
Total assets Rs m276,3666,545 4,222.7%  
Interest coverage x60.21.3 4,773.5%   
Debt to equity ratio x0-1.5 -0.0%  
Sales to assets ratio x0.70.8 92.2%   
Return on assets %14.211.8 120.1%  
Return on equity %19.3-2.1 -937.9%  
Return on capital %24.724.9 99.0%  
Exports to sales %43.075.6 56.9%   
Imports to sales %9.94.2 235.3%   
Exports (fob) Rs m84,1173,796 2,215.8%   
Imports (cif) Rs m19,274211 9,155.9%   
Fx inflow Rs m84,1173,893 2,160.5%   
Fx outflow Rs m19,274289 6,680.1%   
Net fx Rs m64,8433,605 1,798.8%   
CASH FLOW
From Operations Rs m32,279153 21,120.9%  
From Investments Rs m-14,752766 -1,925.7%  
From Financial Activity Rs m-18,104-421 4,302.2%  
Net Cashflow Rs m-748498 -150.2%  

Share Holding

Indian Promoters % 75.0 55.6 134.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.2 0.0 -  
FIIs % 7.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 44.4 56.3%  
Shareholders   370,863 18,028 2,057.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs IND. SWIFT

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs IND. SWIFT Share Price Performance

Period Cadila Healthcare IND. SWIFT S&P BSE HEALTHCARE
1-Day -0.24% 0.96% 0.65%
1-Month -4.68% 5.02% -0.82%
1-Year 46.67% 17.65% 42.80%
3-Year CAGR 27.34% 23.10% 20.12%
5-Year CAGR 30.27% 41.73% 26.10%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the IND. SWIFT share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of IND. SWIFT the stake stands at 55.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of IND. SWIFT.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 7.9%.

IND. SWIFT paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of IND. SWIFT.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.